Bristol Myers Squibb - Factbites
 Factbites
 Where results make sense
About us   |   Why use us?   |   Reviews   |   PR   |   Contact us  

Topic: Bristol Myers Squibb


    Note: these results are not from the primary (high quality) database.


Related Topics

In the News (Sun 5 Jul 09)

  
 Bristol-Myers Squibb - SourceWatch
Britsol Myers Squibb is one of the world's largest drug companies, with global sales of $19.4 billion in 2004.
If you find SourceWatch useful, please consider making a donation to its sponsor, the Center for Media and Democracy.
www.sourcewatch.org /index.php?title=Bristol-Myers_Squibb   (152 words)

  
 ScienceDaily.com Wire Release: Bristol-Myers Squibb Statement on Muraglitazar, an Investigational Oral Treatment For Type 2 Diabetes
Bristol-Myers Squibb will continue discussions with the FDA and will consider a range of options including conducting additional studies or terminating further development of muraglitazar.
Bristol-Myers Squibb is a global pharmaceutical and related health care products company whose mission is to extend and enhance human life.
In addition, Bristol-Myers Squibb has agreed to begin discussions with Merck to terminate the collaborative agreement.
sciencedaily.mediwire.com /main/default.aspx?p=Release&PwID=1109   (245 words)

  
 Bristol-Myers Squibb - Wikipedia, the free encyclopedia
Bristol-Myers Squibb NYSE: BMY, colloquially referred to as BMS, is a pharmaceutical corporation, formed by a 1989 merger between pharmaceutical companies Bristol-Myers Company and Squibb Corporation.
The following is a list of key pharmaceutical products as found on the Bristol-Myers Squibb "At A Glance" information page, retrieved 2005-03-28.
Bristol-Myers Squibb manufactures prescription pharmaceuticals, Over-the-Counter drugs (see Excedrin) and health care products in several therapeutic areas.
en.wikipedia.org /wiki/Bristol-Myers_Squibb   (245 words)

  
 Bristol-Myers Squibb Taps Grid Computing
You can't see it from the country road in western New Jersey, but in a brick building behind a dairy farm and across a corn field, a group of Bristol-Myers Squibb scientists and technology project managers are working on one of the largest "grid computing" systems in the world.
Project managers at Bristol-Myers Squibb think they can aggregate the processing power of thousands of under-utilized PCs—and save the drugmaker millions in the process.
Baseline is a registered trademark of, and the Baseline signature line, Case Dissection, Topline and Retrospect are trademarks of, Ziff Davis Publishing Holdings Inc.
www.baselinemag.com /article2/0,1397,664156,00.asp   (1218 words)

  
 Bristol-Myers Squibb CIO on IT and Pharmaceutical Data
Daniel E. Klingler, Ph.D., as CIO and senior vice president of Information and Knowledge Management for the Worldwide Medicines Group at Bristol-Myers Squibb, oversees all of the business processes that are part of the company's pharmaceutical business.
Klingler has responsibility for developing, delivering and supporting all of the applications that are used within the pharmaceutical area, including scientific R&D. CIO Insight spoke with him recently about the role of IT in the drug business—and how good project management rules can help speed results.
Knowledge management is still an elusive concept for many CIOs, but not in the pharmaceutical industry, where collaboration and high-speed data discovery is key to future profit.
www.cioinsight.com /article2/0,1540,646432,00.asp   (1728 words)

  
 Bristol-Myers Squibb Net Slumps
Bristol-Myers Squibb, however, also repeated that it expects "substantial incremental sales losses" in 2005, 2006 and 2007, representing continuing declines in sales of the products that lost or will lose exclusivity protection in 2003 and 2004, and additional declines attributable to products that will lose exclusivity protection primarily in 2005 and 2006.
The company reaffirmed its previous full-year EPS guidance of $1.60 to $1.65 on an adjusted non-GAAP basis.
Health officials will include the company's flu vaccine in a federal program for children.
www.thestreet.com /_googlen/stocks/biotech/10191442_2.html   (1728 words)

  
 Company News On Call
Bristol-Myers Squibb is a diversified, worldwide health and personal care company whose principal businesses are pharmaceuticals, consumer medicines, beauty care, nutritionals, and medical devices.
Bristol-Myers Squibb is the largest manufacturer of penicillin in the world and the maker of some of the most prescribed antibiotics for adults and children, including TRIMOX(R) (amoxicillin), PRINCIPEN(R) (ampicillin), CEFZIL(R) (cefprozil) and DURICEF(R) (cefadroxil).
"Bristol-Myers Squibb is very pleased to work with Schering-Plough to help physicians treat the RTIs that affect people every day, especially this time of year," said Richard J. Lane, president, Bristol-Myers Squibb Worldwide Medicines Group.
www.prnewswire.com /cgi-bin/stories.pl?ACCT=105&STORY=/www/story/03-13-2000/0001162915   (1728 words)

  
 SWBIC - Bristol-Myers Squibb Company (more info)
Bristol-Myers Squibb is a health and personal care company whose principal businesses are medicines, beauty care, nutritionals, and medical devices.
darwin.nmsu.edu /cgi-bin/moreinfo.cgi?12262   (1728 words)

  
 About Bristol-Myers Squibb Company
In 1967, Mead Johnson merged with Bristol-Myers Company and triggered an expansion of the Company.
The company's mission began in 1887 in New York where two friends - William M. Bristol and John Ripley Myers - founded a company to sell medicines directly to doctors.
Mead Johnson was devoted to nutrition research and development and soon expanded to pediatrics and infant nutrition; E.R. Squibb and Son, Inc., was known for its meticulous standards of quality that revolutionized the development, manufacture and control of medical preparations.
www.bms.com.ph /about.htm   (1728 words)

  
 BRISTOL-MYERS SQUIBB COMPANY Jobs - Employment Opportunities at Monster.com
We pledge Bristol-Myers Squibb to the highest standard of moral and ethical behavior and to policies and procedures that fully embody the responsibility, integrity and decency required of free enterprise if it is to merit and maintain the confident of our society.
Bristol-Myers Squibb is one of the great companies of the world, dedicated to extending and enhancing human life by providing the finest health and personal care products.
As a world leader in medicines, beauty and personal care products, nutritionals and medical devices, Bristol-Myers Squibb is dedicated to competitive superiority and to improving the lives of our millions of customers.
company.monster.com /bms   (1728 words)

  
 Datamonitor - PharmaVitae 2005: Bristol-Myers Squibb Global Analysis - Company Analysis Report
Benchmark Bristol Myers Squibb's performance against key rivals in the ethical pharmaceutical and biotechnology sector.
Discover why Bristol-Myers Squibb's organic growth prospects are low at a forecast CAGR of 1.8% from 2004 to 2010.
Gain insight into why Bristol-Myers Squibb's generic risk is one of the highest among the top-tier pharmaceutical companies.
www.datamonitor.com /industries/research/?pid=CSHC1213&type=CompanyReport   (1728 words)

  
 Bristol-Myers Squibb Company --  Encyclopædia Britannica
Bristol is also the home of the New England Carousel Museum and the...
This west coast port is located 8 miles (13 kilometers) from the broad Severn Estuary, at the junction of the Frome and Avon rivers, in the historic counties of Gloucestershire and Somerset.
American company resulting from a merger in 1989 and dating to companies founded in 1858 and 1887.
www.britannica.com /eb/article-9016502?tocId=9016502   (1728 words)

  
 CW Resource
Officials of Bristol-Myers Squibb, one of the world's largest pharmaceuticals companies, have met with Securities and Exchange regulators to discuss circumstances behind last year's sales to drug wholesalers.
Several months ago, Bristol admitted that it was reducing shipments to wholesales in order to bring wholesaler inventories to a more appropriate level.
There is no evidence at this time that Bristol behaved improperly or artificially inflated sales.
myphlip.pearsoncmg.com /cw/mpviewce.cfm?vceid=3369&vbcid=3463   (1728 words)

  
 Stocks close higher, rallying on earnings - Boston.com - Markets - Business
The company said 2005 profit should be at the upper end of its forecast .
Second-quarter profits of SandP 500 companies are now seen rising 10.1 percent, marking 13 straight quarters of double-digit profit growth, according to Reuters Estimates.
The company's second-quarter profit almost doubled to $1 billion on higher sales, beating Wall Street expectations.
www.boston.com /business/markets/articles/2005/07/28/us_blue_chips_open_higher_exxon_gains   (1728 words)

  
 BRISTOL-MYERS SQUIBB COMPANY, New York, NY
At Bristol-Myers Squibb (http://www.bms.com), our mission is to extend and enhance human life by providing the highest-quality pharmaceuticals and health care products.
What has enabled Bristol-Myers Squibb to achieve market leadership is an unwavering commitment to the values of excellence, reliability, growth, innovation, fairness and good citizenship.
Living--and living up to--the Bristol-Myers Squibb Pledge is crucial to our mission to extend and enhance human life, and is key to our future success.
www.aeaweb.org /joe/0502d/html/joe059.html   (1728 words)

  
 540.doc
Bristol-Myers Squibb is a diversified world-wide health and personal care company whose principal business is pharmaceuticals, consumer products, nutritionals and medical devices.
All such sales are effected through a subsidiary company of Bristol-Myers Squibb Company established within the State, Bristol-Myers Squibb Pharmaceuticals Limited, which is responsible for the marketing and sale of all Bristol-Myers Squibb pharmaceutical products in Ireland.
Notification was made by E.R. Squibb & Clonmel Healthcare Ltd on 15 August 1996 with a request for a certificate under Section 4(4) of the Competition Act 1991 or, in the event of a refusal by the Competition Authority to grant a certificate, a licence under Section 4(2) in respect of an exclusive licensing agreement.
www.tca.ie /decisions/540.doc   (1728 words)

  
 Globeinvestor.com: Bristol-Myers Squibb Announces Settlement With Opt Out Plaintiffs From Securities Class Action Litigation
Bristol-Myers Squibb Company is a global pharmaceutical and related health care products company whose mission is to extend and enhance human life.
The company expects in the second quarter to reserve an additional amount which will be material to the company's operating results, but not its financial condition, for the remaining matters.
As previously disclosed, the company has established an aggregate reserve of $140 million, which includes the $89 million settlement amount discussed above, for liabilities in relation to investigations and certain litigation arising out of wholesaler inventory issues and other accounting matters.
www.globeinvestor.com /servlet/ArticleNews/print/PRNEWS/20050601/2005_06_01_18_2513_1381965   (1728 words)

  
 CSRwire.com -- Corporate Social Responsibility Newswire
As part of SECURE THE FUTURE, the company has created the Bristol-Myers Squibb HIV Research Institute to advance medical research by providing grants to fund research and training specifically designed to build health care infrastructure and achieve model programs for AIDS management.
The company also has what is called a "take back program," where customers are encouraged to return their old carpet for recycling regardless of the original manufacturer.
When they state that their company's mission is, "to improve the quality of life for our growing corporate community," they mean it.
www.csrwire.com /print.cgi?sfArticleId=69   (1728 words)

  
 Globeinvestor.com: CommonHealth's Ferguson Celebrates 30th Anniversary
In 1993, the Ferguson Communications Group of companies (consisting of Ferguson, ProCom and a number of other business units evolving from the desire to address client needs outside of the professional advertising realm) allied with HLS (Health Learning Systems), a sister medical education company within the WPP Group, to establish the CommonHealth network.
Founded in 1974 by Thomas G. Ferguson, the agency was one of the first in the healthcare communications industry to establish offices in New Jersey to be closer to prospective pharmaceutical clients.
The organization also maintains numerous partnerships both within and outside of the WPP Group network of companies.
www.globeinvestor.com /servlet/ArticleNews/print/BWIRE/20041222/20041222005038   (1728 words)

  
 Bristol-Myers Squibb - Newsroom - Press Release - Bristol-Myers Squibb Company, Baylor College Of Medicine To Establish Pediatric Aids Corps For Africa
Separately, Bristol-Myers Squibb announced it also is reducing the price of pediatric formulations of HIV medicines in the world's least developed countries to expand access to treatment.
Glucophage® and Glucovance® are registered trademarks and Metaglip™ is a trademark of Merck Santé S.A.S., an associate of Merck KGaA of Darmstadt, Germany, licensed to Bristol-Myers Squibb Company.
Bristol-Myers Squibb is a global pharmaceutical and related health care products company whose mission is to extend and enhance human life.
www.bms.com /news/press/data/fg_press_release_5713.html   (1728 words)

  
 About Mead Johnson Nutritionals
Bristol-Myers Squibb is a diversified worldwide health company.
The company's first major success came in 1911 with the introduction of Dextri-Maltose, the forerunner of modern day infant formula, which was developed to meet an important need identified during a conversation with a pediatrician regarding babies dying before their first birthday due to feeding problems.
As he started his company, he explored a variety of products; however, his strongest interest was in scientifically based nutritional products.
www.meadjohnson.ca /about/MJN_Heritage.htm   (1728 words)

  
 Bristol-Myers Squibb Company and Medarex Form Global Development and Commercialization Collaboration for MDX-010
Bristol- Myers Squibb and Medarex will share in the costs of developing MDX-010 and MDX-1379 in the United States and Europe based on a pre-agreed percentage allocation.
About Bristol-Myers Squibb Bristol-Myers Squibb is a global pharmaceutical and related health care products company whose mission is to extend and enhance human life.
Bristol-Myers Squibb will be responsible for all development outside of these territories.
www.medarex.com /cgi-local/item.pl/20041108-641202   (1728 words)

  
 BioSpace News for
Orencia (abatacept;Bristol-Myers Squibb) is the first of a new class of drugs for RA.
SOMERSET, N.J., Sept. 16 /PRNewswire-FirstCall/ -- Ventiv Health, Inc., today announced that it has expanded its service relationship with Bristol-Myers Squibb Company and will be providing Medical Science Liaison assistance to Bristol-Myers Squibb for the anti-bacterial drug Tequin(R).
Ventiv Health, Inc. (VTIV) Provides Medical Science Liaisons To Bristol-Myers Squibb Company (BMY)
www.biospace.com /news_company.cfm?CompanyID=221104   (1728 words)

  
 Mesothelioma News: ERBITUX--Cetuximab--Receives FDA Approval to Treat Irinotecan Refractory or Intolerant Metastatic Colorectal Cancer
Bristol-Myers Squibb is dedicated to the discovery, development and exhaustive exploration of innovative cancer fighting therapies designed to extend and enhance the lives of patients living with cancer.
Bristol-Myers Squibb is a global pharmaceutical and related health care products company whose mission is to extend and enhance human life.
Although the company believes that the expectations reflected in such forward-looking statements are based upon reasonable assumptions, it can give no assurance that its expectations will be achieved.
www.mesotheliomacenter.org /news/2004-02-12.php   (1728 words)

  
 Iowa Priority - Prescription Savings Program
Bristol Myers Squibb, the first manufacturer to participate in Iowa Priority, views the program as a meaningful interim solution for providing access to prescription medications.
Bristol-Myers Squibb Company and Merck & Co., Inc., make many medications commonly prescribed for conditions affecting the elderly in the Iowa Priority Prescription Savings Program, such as diabetes, high cholesterol, hypertension, arthritis, osteoporosis and glaucoma.
DES MOINES, Iowa - March 21, 2002 - Iowa Priority announced today that two of the nation's largest drug manufacturers are now offering Iowa seniors and others on Medicare significant discounts on medications that treat a wide range of medical conditions.
www.iowapriority.org /newsrelease-newmeds.asp   (1728 words)

  
 Bristol-Myers Squibb Pharmaceutical Research Institute (PRI)
Bristol-Myers Squibb is concentrating on a number of other therapeutic areas, including immunology and inflammation (autoimmune/inflammatory disorders, rheumatoid arthritis, organ transplantation); pulmonary disease (asthma, chronic obstructive pulmonary disease, allergic rhinitis); and dermatology (inflammatory diseases, excessive hair growth, pigmentation, psoriasis, wound healing).
The Medal was awarded to Bristol-Myers Squibb "for extending and enhancing human life through innovative pharmaceutical research and development, and for redefining the science of clinical study through groundbreaking and hugely complex clinical trials that are recognized models in the industry."
All of the company's resources and expertise in oncology research and development are marshaled toward the single goal of providing safer and more effective cancer medicines.
www.biospace.com /company_profile.cfm?CompanyID=1319   (1728 words)

  
 BioSpace News for
Merck & Co.'s Zocor, Bristol-Myers Squibb Co.'s Pravachol and other cholesterol-reducing medicines may cut the risk of colon cancer by about half, according to a study in the May 26 issue of the New England Journal of Medicine.
Since researchers first mixed together genes from two species more than a quarter century ago, biotechnology companies have promised to revolutionize the pharmaceutical industry -- and even disrupt centuries of farming practices.
The $0.38 per share dividend is payable on July 1, 2005 to stockholders of record at the close of business on June 3, 2005.
www.biospace.com /news_company.cfm?CompanyID=1440&SR=71   (1728 words)

  
 Corporate Social Responsibility Profile for Bristol-Myers Squibb Company
There are currently no resolutions for Bristol-Myers Squibb Company.
Corporate Social Responsibility Profile for Bristol-Myers Squibb Company
The company stonewalls inquiries related to the resolution, which springs from a $1.5 million settlement with the SEC and DOJ earlier this year regarding a bribe Monstanto paid in Indonesia.
www.socialfunds.com /csr/profile.cgi/278.html   (1728 words)

  
 Bristol Myers Squibb Company - Securities Class Action Securities Litigation Entwistle & Cappucci LLP Legal Firm - Attorneys at Law - Legal Representation
In 2000, class action was filed Bristol Myers Squibb Company in the US District Court for the District of New Jersey.
Bristol-Myers said in a statement that the company had agreed to a separate settlement of $150 million with the Securities and Exchange Commission without admitting or denying any liability, and company executives would not comment on any other investigations into its accounting practices or the future steps it might take.
As part of the so-called "deferred prosecution" agreement, the New York-based company would be able to avoid criminal charges if it complies with certain terms of the settlement, The New York Times and The Wall Street Journal both reported Sunday night on their Web sites, citing unnamed sources familiar with the settlement talks.
www.entwistle-law.com /legal_news/securities-cases/1023/BMY02-01   (1728 words)

  
 Bristol-Myers-Sqibb - .
Bristol Myers Squibb and a Californian company named Beckman Coulter will produce the PLG CD4 test.
Analysts at Lehman Brothers downgrade Bristol Myers Sqibb to “underweight...
Bristol Myers Sqibb, Medical Imaging: Obtained HCPCS codes for...
www.pharmacy-directory.us /dir/379/1.php   (1728 words)

Try your search on: Qwika (all wikis)

Factbites
  About us   |   Why use us?   |   Reviews   |   Press   |   Contact us  
Copyright © 2005-2007 www.factbites.com Usage implies agreement with terms.